Nomacopan Uses, Dosage, Side Effects and more
Nomacopan is under investigation in clinical trial NCT03427060 (Coversin in PNH in Patients With Resistance to Eculizumab Due to Complement C5 Polymorphisms).
Attribute | Details |
---|---|
Trade Name | Nomacopan |
Generic | Nomacopan |
Nomacopan Other Names | COVERSIN, Nomacopan |
Type | |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | January 7, 2025 at 1:49 am |